| # | Title | Journal | Year | Citations |
|---|
| 1 | Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results | Movement Disorders | 2008 | 4,796 |
| 2 | MDS clinical diagnostic criteria for Parkinson's disease | Movement Disorders | 2015 | 4,389 |
| 3 | Clinical diagnostic criteria for dementia associated with Parkinson's disease | Movement Disorders | 2007 | 2,497 |
| 4 | Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan | Movement Disorders | 2007 | 1,097 |
| 5 | MDS research criteria for prodromal Parkinson's disease | Movement Disorders | 2015 | 1,033 |
| 6 | Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force | Movement Disorders | 2007 | 885 |
| 7 | Cardioprotection and lifespan extension by the natural polyamine spermidine | Nature Medicine | 2016 | 801 |
| 8 | A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease | American Journal of Human Genetics | 2011 | 757 |
| 9 | The diagnosis of Parkinson's disease | Lancet Neurology, The | 2006 | 665 |
| 10 | Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study | Brain | 2019 | 636 |
| 11 | Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia | Glia | 2013 | 542 |
| 12 | Non‐motor symptoms in Parkinson’s disease | European Journal of Neurology | 2008 | 524 |
| 13 | Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial | Lancet Neurology, The | 2010 | 476 |
| 14 | EFNS/MDS‐ES recommendations for the diagnosis of Parkinson's disease | European Journal of Neurology | 2013 | 460 |
| 15 | Narcolepsy is strongly associated with the T-cell receptor alpha locus | Nature Genetics | 2009 | 445 |
| 16 | The natural history of multiple system atrophy: a prospective European cohort study | Lancet Neurology, The | 2013 | 426 |
| 17 | Telomere Length and Risk of Incident Cancer and Cancer Mortality | JAMA - Journal of the American Medical Association | 2010 | 414 |
| 18 | Overlapping demyelinating syndromes and anti–N‐methyl‐D‐aspartate receptor encephalitis | Annals of Neurology | 2014 | 405 |
| 19 | The Onset of Nonmotor Symptoms in Parkinson's disease (The ONSET PDStudy) | Movement Disorders | 2015 | 402 |
| 20 | Unified EEG terminology and criteria for nonconvulsive status epilepticus | Epilepsia | 2013 | 397 |
| 21 | Idiopathic REM sleep behaviour disorder and neurodegeneration — an update | Nature Reviews Neurology | 2018 | 386 |
| 22 | Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease | Movement Disorders | 2014 | 379 |
| 23 | Factors predictive of the development of Levodopa‐induced dyskinesia and wearing‐off in Parkinson's disease | Movement Disorders | 2013 | 374 |
| 24 | Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial | Lancet Neurology, The | 2007 | 359 |
| 25 | Restless legs syndrome: A community-based study of prevalence, severity, and risk factors | Neurology | 2005 | 352 |
| 26 | Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study | Lancet Neurology, The | 2010 | 349 |
| 27 | Posterior reversible encephalopathy syndrome | Journal of Neurology | 2017 | 344 |
| 28 | Consensus Summary Statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care | Neurocritical Care | 2014 | 339 |
| 29 | Normative EMG Values during REM Sleep for the Diagnosis of REM Sleep Behavior Disorder | Sleep | 2012 | 332 |
| 30 | Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study | Annals of Neurology | 2010 | 330 |
| 31 | Evidence-based medical review update: Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004 | Movement Disorders | 2005 | 327 |
| 32 | A single‐question screen for rapid eye movement sleep behavior disorder: A multicenter validation study | Movement Disorders | 2012 | 311 |
| 33 | Economic burden of stroke: a systematic review on post-stroke care | European Journal of Health Economics | 2019 | 300 |
| 34 | PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study | Lancet Diabetes and Endocrinology,the | 2017 | 298 |
| 35 | The continuum of spreading depolarizations in acute cortical lesion development: Examining Leão’s legacy | Journal of Cerebral Blood Flow and Metabolism | 2017 | 297 |
| 36 | Summary of the recommendations of the EFNS/MDS‐ES review on therapeutic management of Parkinson's disease | European Journal of Neurology | 2013 | 290 |
| 37 | Genome-wide analysis identifies 12 loci influencing human reproductive behavior | Nature Genetics | 2016 | 284 |
| 38 | Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization | Nature Genetics | 2014 | 281 |
| 39 | Multiple system atrophy: A primary oligodendrogliopathy | Annals of Neurology | 2008 | 279 |
| 40 | Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force | European Journal of Neurology | 2006 | 276 |
| 41 | Diabetes Is an Independent Predictor for Severe Osteoarthritis | Diabetes Care | 2013 | 270 |
| 42 | The long-term treatment of restless legs syndrome/Willis–Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group | Sleep Medicine | 2013 | 260 |
| 43 | Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care | Intensive Care Medicine | 2014 | 258 |
| 44 | Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium | JAMA Network Open | 2021 | 255 |
| 45 | Cellular Aging Reflected by Leukocyte Telomere Length Predicts Advanced Atherosclerosis and Cardiovascular Disease Risk | Arteriosclerosis, Thrombosis, and Vascular Biology | 2010 | 253 |
| 46 | PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome | Nature Genetics | 2008 | 252 |
| 47 | Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study | Multiple Sclerosis Journal | 2015 | 249 |
| 48 | Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study | Annals of Neurology | 2015 | 248 |
| 49 | Guidelines for the first-line treatment of restless legs syndrome/Willis–Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation | Sleep Medicine | 2016 | 242 |
| 50 | Neural correlates of distance and congruity effects in a numerical Stroop task: an event-related fMRI study | NeuroImage | 2005 | 239 |
